You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Fertility, pregnancy and childbirth
  5. Intrapartum care

Intrapartum care

  • NICE guideline
  • Reference number: NG235
  • Published:  29 September 2023
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History
Download guidance (PDF)
  • Overview
  • Recommendations
  • Recommendations for research
  • Rationale and impact
  • Context
  • Appendix A: Adverse outcomes for different places of birth
  • Appendix B: Outcomes for different places of birth – by BMI at booking
  • Appendix C: Outcomes for intravenous remifentanil patient-controlled analgesia (PCA) compared with intramuscular pethidine
  • Finding more information and committee details
  • Update information

Finding more information and committee details

To find NICE guidance on related topics, including guidance in development, see the NICE topic page on fertility, pregnancy and childbirth.

For full details of the evidence and the guideline committee's discussions, see the evidence reviews. You can also find information about how the guideline was developed, including details of the committee.

NICE has produced tools and resources to help you put this guideline into practice. For general help and advice on putting our guidelines into practice, see resources to help you put NICE guidance into practice.


Next page Update information Previous page Appendix C: Outcomes for intravenous remifentanil patient-controlled analgesia (PCA) compared with intramuscular pethidine